The U.S. FDA on Feb. 6 granted Breakthrough Device Designation to medical device developer Aria CV, Inc., for its Aria CV Pulmonary Hypertension System.
People who begin taking antihypertensive drugs or lipid-lowerers like statins are more likely than non-initiators to become obese and physically inactive, a JAHA study has found—but they’re also more likely to quit smoking and keep their alcohol intake in check.
Despite other quality of life improvements, heart patients supported by left ventricular assist devices face “severely impaired” exercise capacity, according to a study published online in JACC: Heart Failure.
A presidential advisory published by the American Heart Association on Feb. 3 outlines a set of healthcare principles focused on eliminating inequities in the healthcare system, promoting diversity and better addressing social determinants of health.
Higher visit-to-visit systolic blood pressure variability early in life may predict CVD and all-cause mortality in middle age, according to research published in JAMA Cardiology on Jan. 22.
A Massachusetts General Hospital physician was instrumental in getting two new medical emojis—an anatomically correct heart and a pair of lungs—approved for an update later this year, the Boston Globe reported Feb. 4.
A study published in JACC: Cardiovascular Interventions this month found that patients who suffer from migraines may find long-term relief after transcatheter patent foramen ovale closure.
A Seattle-based scientist has received a quarter of a million dollars to streamline MR imaging and analysis, the American Heart Association announced Jan. 29.
Medtronic has received CE mark approval in the European Union for its Cobalt and Crome implantable cardioverter-defibrillators and cardiac resynchronization therapy-defibrillators.
